Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Diagnostic performance of brain 18F-FDG PET in predicting CSF biomarker patterns

From: 18F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis

 

PET scans showing a neurodegenerative pattern

PET scans showing an Alzheimer’s disease pattern

A+

  

 Se

76%

31%

 Sp

38%

91%

 PPV

52%

75%

 NPV

63%

69%

 Acc

56%

62%

T+

  

 Se

74%

26%

 Sp

44%

94%

 PPV

76%

92%

 NPV

42%

35%

 Acc

66%

46%

N+

  

 Se

86%

29%

 Sp

33%

81%

 PPV

14%

17%

 NPV

95%

90%

 Acc

39%

75%

A+/T+

  

 Se

81%

38%

 Sp

38%

90%

 PPV

40%

67%

 NPV

79%

73%

 Acc

52%

72%

  1. Data from patient medical records (N = 61). Abbreviations: Se, sensitivity; Sp, specificity; PPV, positive predictive value; NPV, negative predictive value; Acc, accuracy; A for amyloid biomarker, T for tau biomarker and N for neurodegeneration biomarker